The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1513
January 30, 2017
View Complete Issue         Table of Contents 2019 
Yosprala - A Combination of Aspirin and Omeprazole
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Yosprala - A Combination of Aspirin and Omeprazole
January 30, 2017 (Issue: 1513)
The FDA has approved Yosprala (Aralez), a fixed-dose combination of delayed-release aspirin and immediate-release omeprazole, for secondary prevention of cardiovascular and cerebrovascular events in patients who are at risk of developing...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Yosprala - A Combination of Aspirin and Omeprazole
Article code: 1513d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.